S011806 (DC-806 or LY4100504)

DC-806 / LY4100504 · DICE Therapeutics, Inc. (a wholly owned subsidiary of Eli Lilly and Company)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for S011806 (DC-806 or LY4100504), covering 2025-02-05 to 2025-02-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess S011806 (DC-806 or LY4100504) in Healthy Adult Participants and Participants With Chronic Plaque Psoriasis [Phase 1]

See pricing